ETR: The One Indispensable Quality - Do You Have It?
August 20, 2009 - Issue #2750
Dear ETR Reader -
If you are not yet a master marketer, now is the time to make a conscious decision to become one. All you need to do -- this very second -- is make the decision: "I will master the science of selling." Say it. Mean it. Say it again.
In today's issue:
Why Stocks Must Take a Hit This Year
Two-thirds of the U.S. economy is driven by consumer spending. That's the reason our politicians keep telling us to spend.
Spending itself is not bad. But spending more than you have -- that's plain stupid. Yet, that is what the Bush administration told us to do in 2005, 2006, and 2007. Consumer spending, compared to disposable income, hit its peak in 2007. Americans were spending 32 percent more than they had.
Since then, consumers have slowed down their spending. But just a bit. Last year, we outspent our income by 24 percent.
The long-term solution, our own Steve McDonald says, is painful: Save and invest. Hard to convince most people to do it.
The Obama administration's solution is taxing more, borrowing less, and spending more. A logical impossibility.
What does this mean for investors?
Steve says the reduced spending will cut into growth and affect the stock market. "If you plan to make money long-term," he says, "diversify out of the stock market. Corporate bonds are a logical choice. They allow you to sidestep the market's crazy volatility. And they can give you super-safe returns as good as or better than stocks."
How Drug Companies Are Fighting Generics
When it comes to Advil, I'm a brand sucker. I know I can get the same stuff for a fraction of the price by buying a generic. But I can't get the reptilian part of my brain to accept that.
Generics become available when a drug's patent expires. Big pharmaceutical companies hate when this happens. It greatly reduces their profit margins. Walmart and other retailers offer $4 per month prescriptions on many generics. That's nearly a $100 savings on brands like Lipitor.
Big Pharma is fighting back with a strategy they call "pay for delay." They're making deals with generic drug makers to delay the launch of their copies. According to The Economist, the FTC estimates these deals cost Americans $3.5 billion a year. The Justice Department has said the practice is probably illegal. (They are investigating further.)
Most prescription drugs aren't necessary. But if you need to take them, Total Health Breakthroughs editor Melanie Segala says, generics are by far the most cost-effective way.
The One Thing That Changes EverythingBy Alex Green
One indispensable quality affects every relationship in your life.
It holds together all your associations. It determines whether you realize your dreams, both personal and professional.
"There is one thing that is common to every individual, relationship, team, family, organization, nation, economy, and civilization throughout the world -- one thing which, if removed, will destroy the most powerful government, the most thriving economy, the most influential leadership, the greatest friendship, the strongest character, the deepest love.
"On the other hand, if developed and leveraged, that one thing has the potential to create unparalleled success and prosperity in every dimension of life. Yet, it is the least understood, most neglected, and most underestimated possibility of our time.
|Whitelist Our Email | Click Here to Unsubscribe | Customer Service | Feed Back|
Copyright © 2009 Early to Rise, LLC.
NOTE: If URLs do not appear as live links in your e-mail program, please cut and paste the full URL into the location or address field of your browser. Disclaimer: Early to Rise only recommends products that we've either personally checked out ourselves, or that come from people we know and trust. For doing so, we receive a commission. We will never recommend any product that does not have a 100% money-back satisfaction guarantee.
Nothing in this e-mail should be considered personalized Financial Advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized Financial Advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
To unsubscribe from Early to Rise and any associated external offers, Click here.
To contact us, please visit... http://www.supportatetr.com/helpdesk To cancel or for any other subscription issues, write us at: Order Processing Center
Attn: Customer Service
PO Box 7835
Delray Beach, Florida 33482